The current institutional shareholding score of ALX Oncology Holdings Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 38.46%, representing a quarter-over-quarter decrease of 62.05%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.54% of shares outstanding, with 0.81% decrease in holdings.